Caribou Biosciences, Inc. (CRBU)
0.4969
+0.04
(+7.97%)
USD |
NASDAQ |
Oct 12, 16:00
0.4994
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Free Cash Flow (Quarterly) : -22.79M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.79M |
| March 31, 2026 | -27.06M |
| December 31, 2025 | -20.61M |
| September 30, 2025 | -25.30M |
| June 30, 2025 | -28.68M |
| March 31, 2025 | -37.77M |
| December 31, 2024 | -35.99M |
| September 30, 2024 | -33.33M |
| June 30, 2024 | -35.11M |
| March 31, 2024 | -38.65M |
| December 31, 2023 | -23.66M |
| September 30, 2023 | -33.54M |
| June 30, 2023 | -17.74M |
| Date | Value |
|---|---|
| March 31, 2023 | -29.97M |
| December 31, 2022 | -26.80M |
| September 30, 2022 | -23.73M |
| June 30, 2022 | -24.49M |
| March 31, 2022 | -22.40M |
| December 31, 2021 | -22.07M |
| September 30, 2021 | -15.90M |
| June 30, 2021 | -16.96M |
| March 31, 2021 | 20.29M |
| December 31, 2020 | -8.103M |
| September 30, 2020 | -8.705M |
| June 30, 2020 | -7.258M |
| March 31, 2020 | -9.466M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -84.92M |
| Vir Biotechnology, Inc. | 123.29M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.30M |